Global Blood Therapeutics, Inc. EBITDA 2015-2022 | GBT
Global Blood Therapeutics, Inc. ebitda from 2015 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Global Blood Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2021 | $-279 |
| 2020 | $-232 |
| 2019 | $-273 |
| 2018 | $-179 |
| 2017 | $-117 |
| 2016 | $-82 |
| 2015 | $-46 |
| 2014 | $-20 |
| 2013 | $-15 |
| Global Blood Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2022-06-30 | $-73 |
| 2022-03-31 | $-71 |
| 2021-12-31 | $-81 |
| 2021-09-30 | $-65 |
| 2021-06-30 | $-64 |
| 2021-03-31 | $-69 |
| 2020-12-31 | $-56 |
| 2020-09-30 | $-57 |
| 2020-06-30 | $-49 |
| 2020-03-31 | $-71 |
| 2019-12-31 | $-98 |
| 2019-09-30 | $-67 |
| 2019-06-30 | $-59 |
| 2019-03-31 | $-51 |
| 2018-12-31 | $-50 |
| 2018-09-30 | $-45 |
| 2018-06-30 | $-42 |
| 2018-03-31 | $-42 |
| 2017-12-31 | $-41 |
| 2017-09-30 | $-29 |
| 2017-06-30 | $-24 |
| 2017-03-31 | $-23 |
| 2016-12-31 | $-27 |
| 2016-09-30 | $-21 |
| 2016-06-30 | $-18 |
| 2016-03-31 | $-16 |
| 2015-12-31 | $-15 |
| 2015-09-30 | $-15 |
| 2015-06-30 | $-8 |
| 2015-03-31 | $-7 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-5 |
| 2014-06-30 | $-5 |
| 2014-03-31 | $-5 |
